Sandrine Reigadas

1.2k total citations
34 papers, 634 citations indexed

About

Sandrine Reigadas is a scholar working on Virology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Sandrine Reigadas has authored 34 papers receiving a total of 634 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Virology, 18 papers in Infectious Diseases and 16 papers in Molecular Biology. Recurrent topics in Sandrine Reigadas's work include HIV Research and Treatment (22 papers), HIV/AIDS drug development and treatment (18 papers) and HIV/AIDS Research and Interventions (8 papers). Sandrine Reigadas is often cited by papers focused on HIV Research and Treatment (22 papers), HIV/AIDS drug development and treatment (18 papers) and HIV/AIDS Research and Interventions (8 papers). Sandrine Reigadas collaborates with scholars based in France, United Kingdom and United States. Sandrine Reigadas's co-authors include Hervé Fleury, Jean‐Jacques Toulmé, Encarnación Martı́nez-Salas, Almudena Pacheco, Michel Ventura, Patrícia Recordon-Pinson, Marie‐Line Andréola, Carmelo Di Primo, Simón Litvak and Michel Castroviejo and has published in prestigious journals such as Nucleic Acids Research, PLoS ONE and Biochemistry.

In The Last Decade

Sandrine Reigadas

34 papers receiving 616 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sandrine Reigadas France 17 321 269 260 127 111 34 634
Daniel Rupp Germany 9 136 0.4× 137 0.5× 259 1.0× 254 2.0× 139 1.3× 12 519
Meijuan Niu Canada 19 672 2.1× 427 1.6× 752 2.9× 249 2.0× 34 0.3× 34 1.2k
Fabien Abdul France 8 252 0.8× 126 0.5× 47 0.2× 386 3.0× 225 2.0× 10 590
Aure Saulnier France 8 126 0.4× 85 0.3× 44 0.2× 164 1.3× 169 1.5× 17 380
Vanessa B. Soros United States 9 300 0.9× 196 0.7× 394 1.5× 201 1.6× 23 0.2× 13 660
Yukie Iwabu Japan 12 151 0.5× 172 0.6× 317 1.2× 149 1.2× 32 0.3× 22 536
Xiao-Fang Yu United States 9 218 0.7× 184 0.7× 262 1.0× 117 0.9× 14 0.1× 10 486
Joke Snoeck Belgium 11 145 0.5× 369 1.4× 445 1.7× 219 1.7× 145 1.3× 20 663
Beth Ann Antoni United States 8 194 0.6× 121 0.4× 136 0.5× 135 1.1× 28 0.3× 8 431
Yann Le Duff United Kingdom 8 259 0.8× 77 0.3× 117 0.5× 101 0.8× 48 0.4× 10 421

Countries citing papers authored by Sandrine Reigadas

Since Specialization
Citations

This map shows the geographic impact of Sandrine Reigadas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandrine Reigadas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandrine Reigadas more than expected).

Fields of papers citing papers by Sandrine Reigadas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandrine Reigadas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandrine Reigadas. The network helps show where Sandrine Reigadas may publish in the future.

Co-authorship network of co-authors of Sandrine Reigadas

This figure shows the co-authorship network connecting the top 25 collaborators of Sandrine Reigadas. A scholar is included among the top collaborators of Sandrine Reigadas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandrine Reigadas. Sandrine Reigadas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
André‐Garnier, Elisabeth, Laurence Bocket, Thomas Bourlet, et al.. (2024). Use of genotypic HIV DNA testing: a DELPHI-type consensus. Journal of Antimicrobial Chemotherapy. 79(3). 578–588. 3 indexed citations
2.
Recordon-Pinson, Patrícia, Gwendaline Guidicelli, Pantxika Bellecave, et al.. (2014). Kinetics of HIV-1 CTL Epitopes Recognized by HLA I Alleles in HIV-Infected Individuals at Times near Primary Infection: The Provir/Latitude45 Study. PLoS ONE. 9(6). e100452–e100452. 5 indexed citations
3.
Chirouze, Catherine, Valérie Journot, Vincent Le Moing, et al.. (2014). Viremia Copy-Years as a Predictive Marker of All-Cause Mortality in HIV-1–Infected Patients Initiating a Protease Inhibitor–Containing Antiretroviral Treatment. JAIDS Journal of Acquired Immune Deficiency Syndromes. 68(2). 204–208. 13 indexed citations
4.
Bellecave, Pantxika, et al.. (2013). Detection of Low-Frequency HIV Type 1 Reverse Transcriptase Drug Resistance Mutations by Ultradeep Sequencing in Naive HIV Type 1-Infected individuals. AIDS Research and Human Retroviruses. 30(2). 170–173. 17 indexed citations
5.
Trimoulet, Pascale, Patrícia Recordon-Pinson, Juliette Foucher, et al.. (2013). Dynamic and Rapid Changes in Viral Quasispecies by Udps in Chronic Hepatitis C Patients Receiving Telaprevir-Based Therapy. Antiviral Therapy. 18(5). 723–727. 11 indexed citations
6.
Cosnefroy, Ophélie, Christina Calmels, Vincent Parissi, et al.. (2013). Activation of GCN2 upon HIV-1 infection and inhibition of translation. Cellular and Molecular Life Sciences. 70(13). 2411–2421. 17 indexed citations
7.
Recordon-Pinson, Patrícia, Estibaliz Lazaro, Sandrine Reigadas, et al.. (2013). Resistance Mutations and CTL Epitopes in Archived HIV-1 DNA of Patients on Antiviral Treatment: Toward a New Concept of Vaccine. PLoS ONE. 8(7). e69029–e69029. 14 indexed citations
8.
Recordon-Pinson, Patrícia, et al.. (2012). K65R in Subtype C HIV-1 Isolates from Patients Failing on a First-Line Regimen Including d4T or AZT: Comparison of Sanger and UDP Sequencing Data. PLoS ONE. 7(5). e36549–e36549. 12 indexed citations
9.
Armenia, Daniele, Isabelle Malet, Lavinia Fabeni, et al.. (2011). Impact of baseline HIV-1 integrase polymorphisms on virological outcome in a large European cohort of patients starting a raltegravir-containing regimen. Antiviral Therapy. 16(4). 1 indexed citations
10.
Trimoulet, P., Muriel Faure, Linda Wittkop, et al.. (2011). Hepatitis C virus (HCV) protease variability and anti-HCV protease inhibitor resistance in HIV/HCV-coinfected patients. HIV Medicine. 12(8). 506–509. 22 indexed citations
11.
Reigadas, Sandrine, Guerric Anies, Bernard Masquelier, et al.. (2010). The HIV-1 Integrase Mutations Y143C/R Are an Alternative Pathway for Resistance to Raltegravir and Impact the Enzyme Functions. PLoS ONE. 5(4). e10311–e10311. 27 indexed citations
12.
Reigadas, Sandrine, Marie‐Line Andréola, Linda Wittkop, et al.. (2010). Evolution of 2-long terminal repeat (2-LTR) episomal HIV-1 DNA in raltegravir-treated patients and in in vitro infected cells. Journal of Antimicrobial Chemotherapy. 65(3). 434–437. 21 indexed citations
13.
Reigadas, Sandrine, et al.. (2009). Pol Bootscanning Analysis of HIV Type 1 Can Exhibit Unexpected Recombinations. AIDS Research and Human Retroviruses. 25(7). 713–716. 8 indexed citations
14.
Reigadas, Sandrine, et al.. (2009). Quantitation of HIV-1 RNA in dried blood and plasma spots. Journal of Virological Methods. 161(1). 177–180. 29 indexed citations
15.
Chabas, Sandrine, Sandrine Reigadas, Czeslaw Wychowski, et al.. (2008). A functional selection of viral genetic elements in cultured cells to identify hepatitis C virus RNA translation inhibitors. Nucleic Acids Research. 36(15). e95–e95. 2 indexed citations
16.
Primo, Carmelo Di, et al.. (2007). Systematic screening of LNA/2′‐O‐methyl chimeric derivatives of a TAR RNA aptamer. FEBS Letters. 581(4). 771–774. 33 indexed citations
17.
Darfeuille, Fabien, Sandrine Reigadas, Jens Bo Hansen, et al.. (2006). Aptamers Targeted to an RNA Hairpin Show Improved Specificity Compared to that of Complementary Oligonucleotides. Biochemistry. 45(39). 12076–12082. 52 indexed citations
18.
Reigadas, Sandrine, Almudena Pacheco, Jorge Ramajo, Sonia López de Quinto, & Encarnación Martı́nez-Salas. (2005). Specific interference between two unrelated internal ribosome entry site elements impairs translation efficiency. FEBS Letters. 579(30). 6803–6808. 9 indexed citations
19.
Reigadas, Sandrine, Michel Ventura, Marie‐Line Andréola, et al.. (2003). An oligonucleotide complementary to the SL-B1 domain in the 3′-end of the minus-strand RNA of the hepatitis C virus inhibits in vitro initiation of RNA synthesis by the viral polymerase. Virology. 314(1). 206–220. 4 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniel Rupp Breakdown of academic impact, for papers by Meijuan Niu Breakdown of academic impact, for papers by Fabien Abdul Breakdown of academic impact, for papers by Aure Saulnier Breakdown of academic impact, for papers by Vanessa B. Soros Breakdown of academic impact, for papers by Yukie Iwabu Breakdown of academic impact, for papers by Xiao-Fang Yu Breakdown of academic impact, for papers by Joke Snoeck Breakdown of academic impact, for papers by Beth Ann Antoni Breakdown of academic impact, for papers by Yann Le Duff
Rankless by CCL
2026